ALDH1A3 regulates invasion ability of pancreatic cancer cells

Jiao CAI; Fu LI; Jiangjie DUAN; Shicang YU

doi:10.16016/j.1000-5404.201904084

您当前的位置：

首页 >

文章列表页 >

ALDH1A3 regulates invasion ability of pancreatic cancer cells

Basic Medicine | 更新时间：2026-01-09

- ALDH1A3 regulates invasion ability of pancreatic cancer cells
- Journal of Third Military Medical University Vol. 41, Issue 17, Pages: 1642-1648(2019)
- 作者机构：
  
  1.400038 重庆，陆军军医大学(第三军医大学) 第一附属医院:全军临床病理学研究所，西南癌症中心
  2.400038 重庆，陆军军医大学(第三军医大学) 第一附属医院:干细胞与再生医学科
  3.400038 重庆，陆军军医大学(第三军医大学) 第一附属医院:肿瘤科
- 作者简介：
- 基金信息：
  
  the National Key Research and Development Program of China(2016YFA0202104)
- DOI：10.16016/j.1000-5404.201904084
  CLC： R345;R730.23;R735.9
- Received：11 April 2019，
  
  Revised：2019-05-07，
  
  Published：15 September 2019
- 稿件说明：
移动端阅览
Jiao CAI, Fu LI, Jiangjie DUAN, et al. ALDH1A3 regulates invasion ability of pancreatic cancer cells[J]. Journal of Third Military Medical University, 2019, 41(17): 1642-1648.
DOI：

Jiao CAI, Fu LI, Jiangjie DUAN, et al. ALDH1A3 regulates invasion ability of pancreatic cancer cells[J]. Journal of Third Military Medical University, 2019, 41(17): 1642-1648. DOI： 10.16016/j.1000-5404.201904084.

摘要

目的

探讨人乙醛脱氢酶家族1成员A3(aldehyde dehydrogenase 1 family member A3，ALDH1A3)在胰腺癌及正常胰腺组织中的表达情况，并研究其对胰腺癌侵袭的调控及可能的机制。

方法

利用癌症和肿瘤基因图谱(the Cancer Genome Atlas，TCGA)数据库中胰腺癌患者数据集、基因组织表达项目(Genotype-Tissue Expression Project，GTEx)中正常胰腺组织基因表达谱数据和肿瘤细胞系百科全书(Cancer Cell Line Encyclopedia，CCLE)数据库中胰腺癌细胞系的基因表达谱矩阵，分析ALDH家族各亚型的表达情况；Transwell实验检测敲低ALDH1A3对胰腺癌细胞侵袭能力的影响；基因富集分析(gene set enrichment analysis，GSEA)探讨ALDH1A3与JAK/STAT3通路活化的关系。

结果

ALDH1A3在胰腺癌组织中的表达高于正常胰腺组织；在胰腺癌细胞系中的表达高于其他ALDH亚型；下调ALDH1A3可以降低胰腺癌细胞系的侵袭能力；JAK/STAT3通路在ALDH1A3高表达胰腺癌患者中显著富集；下调ALDH1A3可抑制STAT3的磷酸化。

结论

ALDH1A3参与调控胰腺癌细胞的侵袭，其机制可能与JAK/STAT3通路的活化有关。

Abstract

Objective

To detect the expression level of aldehyde dehydrogenase 1 family member A3 (ALDH1A3) in pancreatic cancer and adjacent tissues

and to study its specific mechanism involved in the regulation of invasion of pancreatic cancer cells.

Methods

The ALDH family expression pattern in pancreatic cancer patients and normal pancreatic tissues was analyzed using the gene expression profile matrix of the Cancer Cell Line Encyclopedia (CCLE) database

the Cancer Genome Atlas (TCGA) database and Genotype-Tissue Expression Project (GTEx). Transwell assay was used to detect the invasion of pancreatic cancer cells with silencing of ALDH1A3. Gene set enrichment analysis (GSEA) was employed to further explore the relationship between ALDH1A3 and activation of JAK/STAT3 signaling pathway.

Results

The expression level of ALDH1A3 was significantly higher in pancreatic cancer tissues than adjacent normal tissues

and it was of the highest level when compared with the other subtypes in pancreatic cancer cell lines. Down-regulation of ALDH1A3 resulted in the decreased invasion ability of pancreatic cancer cell lines. JAK/STAT3 pathway was significantly enriched in the pancreatic cancer patients with higher expression of ALDH1A3. The silencing of ALDH1A3 induced the decrease of phospho-STAT3.

Conclusion

ALDH1A3 may be involved in the regulation of pancreatic cancer cell invasion through the JAK/STAT3 pathway.

关键词

Keywords

references

MAKOHON-MOORE A, IACOBUZIO-DONAHUE C A. Pancreatic cancer biology and genetics from an evolutionary perspective[J]. Nat Rev Cancer, 2016, 16(9): 553-565. DOI: 10.1038/nrc.2016.66.

MILLER K D, SIEGEL R L, LIN C C, et al . Cancer treatment and survivorship statistics, 2016[J ] . CA: A Cancer J Clin, 2016, 66(4): 271-289. DOI:10.3322/caac.21349.

MARKAR S R, BRODIE B, CHIN S T, et al . Profile of exhaled-breath volatile organic compounds to diagnose pancreatic cancer[J ] . Br J Surg, 2018, 105(11): 1493-1500. DOI: 10.1002/bjs.10909.

DUA N J J, CAI J, GUO Y F, et al . ALDH1A3, a metabolic target for cancer diagnosis and therapy[J ] . Int J Cancer, 2016, 139(5): 965-975. DOI:10.1002/ijc.30091.

MA I, ALLAN A L. The role of human aldehyde dehydrogenase in normal and cancer stem cells[J]. Stem Cell Rev, 2011, 7(2):292-306. DOI: 10.1007/s12015-010-9208-4.

MARCATO P, DEAN C A, GIACOMANTONIO C A, et al . Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform[J ] . Cell Cycle, 2011, 10(9): 1378-1384. DOI:10.4161/cc.10.9.15486.

JELSKI W, KUTYLOWSKA E, LANIEWSKA-DUNAJ M, et al . Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) as candidates for tumor markers in patients with pancreatic cancer[J ] . J Gastrointestin Liver Dis, 2011, 20(3): 255-259.

LI G, LI Y, LIU X, et al . Aldh1a3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma[J ] . Cell Death Dis, 2018, 9(12): 1190. DOI: 10.1038/s41419-018-1232-3.

CHANG P M, CHEN C H, YEH C C, et al . Transcriptome analysis and prognosis of ALDH isoforms in human ca ncer[J ] . Sci Rep, 2018, 8(1): 2713. DOI:10.1038/s41598-018-21123-4.

COJOC M, PEITZSCH C, KURTH I, et al . Aldehyde dehydrogenase is regulated by β-Catenin/TCF and promotes radioresistance in prostate cancer progenitor cells[J ] . Cancer Res, 2015, 75(7): 1482-1494. DOI:10.1158/0008-5472.CAN-14-1924.

LI Y Y, CHEN T, ZHU J, et al . High ALDH activity defines ovarian cancer stem-like cells with enhanced invasiveness and EMT progress which are responsible for tumor invasion[J ] . Biochem Biophys Res Commun, 2018, 495(1): 1081-1088. DOI:10.1016/j.bbrc.2017.11.117.

KOENIG U, AMATSCHEK S, MILDNER M, et al . Aldehyde dehydrogenase 1A3 is transcriptionally activated by all-trans-retinoicacid in human epidermal keratinocytes[J ] . Biochem Biophys Res Commun, 2010, 400(2): 207-211. DOI:10.1016/j.bbrc.2010.08.035.

MORETTI A, LI J, DONINI S, et al . Crystal structure of human aldehyde dehydrogenase 1A3 complexed with NAD(+) and retinoic acid[J ] . Sci Rep, 2016, 6(35710): 35710. DOI: 10.1038/srep35710.

KONG B, WU W W, CHENG T, et al . A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling[J ] . Gut, 2016, 65(4): 647-657. DOI:10.1136/gutjnl-2014-307616.

MARCATO P, DEAN C A, PAN D, et al . Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis[J ] . Stem Cells, 2011, 29(1): 32-45. DOI:10.1002/stem.563.

SHAO C, SULLIVAN J P, GIRARD L, et al . Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway[J ] . Clin Cancer Res, 2014, 20(15): 4154-4166. DOI: 10.1158/1078-0432.CCR-13-3292.

HANAHAN D, WEINBERG R A. Hallmarks of cancer: the next generation[J]. Cell, 2011, 144(5): 646-674. DOI: 10.1016/j.cell.2011.02.013.

VANDER HEIDEN M G. Targeting cancer metabolism: A therapeutic window opens[J]. Nat Rev Drug Discov, 2011, 10(9): 671-684. DOI:10.1038/nrd3504.

HALBROOK C J, LYSSIOTIS C A. Employing metabolism to improve the diagnosis and treatment of pancreatic cancer[J]. Cancer Cell, 2017, 31(1): 5-19. DOI: 10.1016/j.ccell.2016.12.006.

CHEN J, XU H, ZOU X, et al . Snail recruits ring1b to mediate transcriptional repression and cell migration in pancreatic cancer cells[J ] . Cancer Res, 2014, 74(16): 4353-4363. DOI: 10.1158/0008-5472.CAN-14-0181.

SHIELDS M A, EBINE K, SAHAI V, et al . Snail cooperates with KrasG12D to promote pancreatic fibrosis[J ] . Mol Cancer Res, 2013, 11(9): 1078-1087. DOI:10.1158/1541-7786.MCR-12-0637.

HOTZ B, ARNDT M, DULLAT S, et al . Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer[J ] . Clin Cancer Res, 2007, 13(16): 4769-4776. DOI:10.1158/1078-0432.CCR-06-2926.

RAGHAVAN S, MEHTA P, WARD M R, et al . Personalized medicine-based approach to model patterns of chemoresistance and tumor recurrence using ovarian cancer stem cell spheroids[J ] . Clin Cancer Res, 2017, 23(22): 6934-6945. DOI:10.1158/1078-0432.CCR-17-0133.

XIAO Z J, LIU J, WANG S Q, et al . NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma[J ] . eLife, 2017, 6. DOI:10.7554/elife.26733.

RAHA D, WILSON T R,PENG J, et al . The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation[J ] . Cancer Res, 2014, 74(13): 3579-3590. DOI: 10.1158/0008-5472.CAN-13-3456.

PAL D, KOLLURU V, CHANDRASEKARAN B, et al . Targeting aberrant expression of Notch-1 in ALDH+ cancer stem cells in breast cancer[J ] . Mol Carcinog, 2017, 56(3): 1127-1136. DOI:10.1002/mc.22579.

KIM I G, KIM S Y, CHOI S I, et al . Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling[J ] . Oncogene, 2014, 33(30): 3908-3917. DOI:10.1038/onc.2013.373.

FENG H L, LIU Y Y, BIAN X C, et al . ALDH1A3 affects colon cancer in vitro proliferation and invasion depending on CXCR4 status[J ] . Br J Cancer, 2018, 118(2): 224-232. DOI:10.1038/bjc.2017.363.

MAO P, JOSHI K, LI J F, et al . Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3[J ] . Proc Natl Acad Sci USA, 2013, 110(21): 8644-8649. DOI:10.1073/pnas.1221478110.

ZHANG W, LIU Y, HU H, et al . ALDH1A3: A marker of mesenchymal phenotype in gliomas associated with cell invasion[J ] . PLoS ONE, 2015, 10(11): e0142856. DOI: 10.1371/journal.pone.0142856.

XIANG Y, LIAO X H, YU C X, et al . MiR-93-5p inhibits the EMT of breast cancer cells via targeting MKL-1 and STAT3[J ] . Exp Cell Res, 2017, 357(1): 135-144. DOI:10.1016/j.yexcr.2017.05.007..

ROKAVEC M, ÖNER M G, LI H, et al . IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis[J ] . J Clin Invest, 2014, 124(4): 1853-1867. DOI:10.1172/jci73531.

LIU J F, DENG W W, CHEN L, et al . Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer[J ] . Mol Carcinog, 2018, 57(3): 429-439. DOI:10.1002/mc.22767.

LIN L, JOU D, WANG Y, et al . STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells[J ] . Int J Oncol, 2016, 49(6 ): 2265-2274. DOI: 10.3892/ijo.2016.3728.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of fibroblast growth factor 21 on migration and invasion of human pancreatic cancer cells in an inflammatory environment

Role of mitophagy in pancreatic cancer cachexia-induced muscle atrophy

Characterizing tumor nicroenvironment features and identifying potential therapeutic targets in patients with diabetes mellitus and pancreatic cancer based on single-cell transcriptome sequencing

Oncolytic influenza virus enhances killing effect of gemcitabine against pancreatic cancer cells—MENG Zihe^1,2, XU Yongru², DENG Zhaoda², ZHANG Yuxin^1,2, YANG Penghui^1,2, HU Ruiping¹ ¹College of Basic Medical Sciences, Inner Mongolia Medical University, Hohhot, Inner Mongolia;²Institute of Hepato-Pancreato-Biliary Surgery, First Medical Center, Chinese PLA General Hospital, Beijing, China

Expression of circRNA-IARS in pancreatic carcinoma and its clinical significance

Related Author

Wei XIAO

Shasha ZHU

Panchun ZHENG

Yaying YANG

WANG Yijie

LI Jianjun

WANG Xuesong

DONG Yan

Related Institution

Department of Pathology, Molecular Medicine Diagnostics Center, Chongqing Medical University

Center for Clinical Molecular Medical Detection, the First Affiliated Hospital of Chongqing Medical University

Department of Oncology， First Affiliated Hospital， Army Medical University （Third Military Medical University）

Department of Oncology， Southwest Cancer Centre

Radiation Treatment Centre， First Affiliated Hospital， Army Medical University （Third Military Medical University）

⁰